GH
Price
$41.79
Change
-$1.70 (-3.91%)
Updated
Apr 3, 02:59 PM (EDT)
Capitalization
2.46B
34 days until earnings call
VCYT
Price
$28.55
Change
-$1.58 (-5.24%)
Updated
Apr 3, 03:02 PM (EDT)
Capitalization
1.66B
40 days until earnings call
Ad is loading...

GH vs VCYT

Header iconGH vs VCYT Comparison
Open Charts GH vs VCYTBanner chart's image
Guardant Health
Price$41.79
Change-$1.70 (-3.91%)
Volume$700
Capitalization2.46B
Veracyte
Price$28.55
Change-$1.58 (-5.24%)
Volume$400
Capitalization1.66B
GH vs VCYT Comparison Chart
Loading...
GH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GH vs. VCYT commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GH is a Hold and VCYT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (GH: $43.49 vs. VCYT: $30.13)
Brand notoriety: GH: Notable vs. VCYT: Not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GH: 54% vs. VCYT: 85%
Market capitalization -- GH: $2.46B vs. VCYT: $1.66B
GH [@Medical Specialties] is valued at $2.46B. VCYT’s [@Medical Specialties] market capitalization is $1.66B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GH’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • GH’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, GH is a better buy in the long-term than VCYT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GH’s TA Score shows that 5 TA indicator(s) are bullish while VCYT’s TA Score has 4 bullish TA indicator(s).

  • GH’s TA Score: 5 bullish, 5 bearish.
  • VCYT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both GH and VCYT are a good buy in the short-term.

Price Growth

GH (@Medical Specialties) experienced а -5.13% price change this week, while VCYT (@Medical Specialties) price change was -2.96% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.03%. For the same industry, the average monthly price growth was +1.96%, and the average quarterly price growth was +1.63%.

Reported Earning Dates

GH is expected to report earnings on May 07, 2025.

VCYT is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Medical Specialties (-4.03% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GH($2.47B) has a higher market cap than VCYT($1.66B). GH YTD gains are higher at: 42.357 vs. VCYT (-23.914). VCYT has higher annual earnings (EBITDA): -49.41M vs. GH (-433.3M). GH has more cash in the bank: 1.17B vs. VCYT (216M). VCYT has less debt than GH: VCYT (12.6M) vs GH (1.35B). GH has higher revenues than VCYT: GH (564M) vs VCYT (361M).
GHVCYTGH / VCYT
Capitalization2.47B1.66B148%
EBITDA-433.3M-49.41M877%
Gain YTD42.357-23.914-177%
P/E RatioN/AN/A-
Revenue564M361M156%
Total Cash1.17B216M541%
Total Debt1.35B12.6M10,746%
FUNDAMENTALS RATINGS
GH vs VCYT: Fundamental Ratings
GH
VCYT
OUTLOOK RATING
1..100
745
VALUATION
overvalued / fair valued / undervalued
1..100
66
Overvalued
82
Overvalued
PROFIT vs RISK RATING
1..100
10087
SMR RATING
1..100
10088
PRICE GROWTH RATING
1..100
3662
P/E GROWTH RATING
1..100
10059
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GH's Valuation (66) in the Medical Or Nursing Services industry is in the same range as VCYT (82) in the Biotechnology industry. This means that GH’s stock grew similarly to VCYT’s over the last 12 months.

VCYT's Profit vs Risk Rating (87) in the Biotechnology industry is in the same range as GH (100) in the Medical Or Nursing Services industry. This means that VCYT’s stock grew similarly to GH’s over the last 12 months.

VCYT's SMR Rating (88) in the Biotechnology industry is in the same range as GH (100) in the Medical Or Nursing Services industry. This means that VCYT’s stock grew similarly to GH’s over the last 12 months.

GH's Price Growth Rating (36) in the Medical Or Nursing Services industry is in the same range as VCYT (62) in the Biotechnology industry. This means that GH’s stock grew similarly to VCYT’s over the last 12 months.

VCYT's P/E Growth Rating (59) in the Biotechnology industry is somewhat better than the same rating for GH (100) in the Medical Or Nursing Services industry. This means that VCYT’s stock grew somewhat faster than GH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GHVCYT
RSI
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 10 days ago
76%
Declines
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Ad is loading...
GH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VCYT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ISCWX79.41N/A
N/A
Voya Multi-Manager International Sm Cp W
GCEAX17.19N/A
N/A
AB Global Core Equity A
APGZX100.77N/A
N/A
AB Large Cap Growth Z
MLCPX9.17N/A
N/A
MainGate MLP C
GTCAX22.53N/A
N/A
Gabelli Global Content & Connect A

VCYT and

Correlation & Price change

A.I.dvisor indicates that over the last year, VCYT has been closely correlated with NTLA. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if VCYT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCYT
1D Price
Change %
VCYT100%
+1.93%
NTLA - VCYT
69%
Closely correlated
+9.69%
VCEL - VCYT
60%
Loosely correlated
+2.84%
AXON - VCYT
58%
Loosely correlated
+3.18%
DNA - VCYT
57%
Loosely correlated
+5.30%
ABCL - VCYT
55%
Loosely correlated
+6.22%
More